Mitsuaki Mitani
About
In The Last Decade
Mitsuaki Mitani
22 papers receiving 446 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 232
- Oncology 108
- Pharmacology 57
- Ecology 49
- Animal Science and Zoology 48
Countries citing papers authored by Mitsuaki Mitani
This map shows the geographic impact of Mitsuaki Mitani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuaki Mitani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuaki Mitani more than expected).
Fields of papers citing papers by Mitsuaki Mitani
This network shows the impact of papers produced by Mitsuaki Mitani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuaki Mitani. The network helps show where Mitsuaki Mitani may publish in the future.
Co-authorship network of co-authors of Mitsuaki Mitani
This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuaki Mitani. A scholar is included among the top collaborators of Mitsuaki Mitani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuaki Mitani. Mitsuaki Mitani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 25 | |
| 2 | 29 | |
| 3 | 1 | |
| 4 | [Experimental study on immunochemotherapy using schizophyllan]. | 4 |
| 5 | Pharmacological and toxicological studies of a new antitumor polysaccharide, schizophyllan. | 19 |
| 6 | 7 | |
| 7 | 3 | |
| 8 | 9 | |
| 9 | 2 | |
| 10 | 8 | |
| 11 | 9 | |
| 12 | 13 | |
| 13 | 18 | |
| 14 | 6 | |
| 15 | 86 | |
| 16 | 10 | |
| 17 | 102 | |
| 18 | 2 | |
| 19 | 30 | |
| 20 | 29 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.